Meditati
- Biotech or pharma, therapeutic R&D
Meditati is a biotech startup striving to develop the first non-MOR treatment for opioid use disorder (OUD). Our proprietary platform exploits polypharmacology in the brain to discover superior treatments for previously intractable indications. Meditati is currently fundraising to further characterize and optimize our flagship program assets in OUD which have shown efficacy in vivo.